Y. Watanabe

发表

In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705

H. Narita, N. Nomura, K. Takahashi, 2002, Antimicrobial Agents and Chemotherapy.

Deglycosylation of antiherpesviral 5-substituted arabinosyluracil derivatives by rat liver extract and enterobacteria cells.

T. Yamaguchi, H. Machida, Y. Watanabe, 1995, Biochemical pharmacology.

Sphingosine 1-Phosphate (S1P) Regulates Vascular Contraction via S1P 3 Receptor: Investigation Based on a New S1P 3 Receptor Antagonist S

N. Mochizuki, N. Takakura, T. Konno, 2010 .

The first immunoglobulin-like domain of porcine nectin-1 is sufficient to confer resistance to pseudorabies virus infection in transgenic mice

P. Chérel, Y. Tomioka, E. Ono, 2006, Archives of Virology.

5′-O-Alkyl and Acyl Prodrugs of 1-β-D-Arabinofuranosyl-E-5-(2-Bromovinyl)Uracil

H. Machida, Y. Watanabe, S. Sakata, 1994 .

Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.

T. Suzutani, T. Yamaguchi, H. Machida, 1997, Antiviral research.

In vitro and in vivo anti-herpes viral activities and biological properties of CV-araU.

H. Machida, Y. Watanabe, S. Sakata, 1994, Antiviral research.

Metabolism of 5'-ether prodrugs of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil in rats.

H. Machida, Y. Watanabe, N. Ashida, 1993, Biochemical pharmacology.

Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.

T. Yokota, K. Konno, S. Shigeta, 1989, Molecular pharmacology.

Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection.

M. Kurokawa, M. Imakita, K. Shiraki, 2001, The Journal of pharmacology and experimental therapeutics.